Quantcast
Injected Polio Vaccine Making A Comeback In Combination With

Injected Polio Vaccine Making A Comeback In Combination With Oral Method

Rebekah Eliason for redOrbit.com - Your Universe Online In the 1960s, a type of polio vaccine injected into the arm was discontinued. New study suggests that re-introducing this vaccine may help eradicate the disease. This study by Imperial...

Latest Vaccination schedule Stories

2014-07-02 16:24:18

LOS ANGELES, July 2, 2014 /PRNewswire/ -- As the number of pertussis cases, also known as whooping cough, reaches epidemic proportions in California, Ralphs Pharmacies continue to offer Tdap (tetanus, diphtheria, pertussis) vaccinations at its 85 in-store pharmacies throughout Southern California. http://photos.prnewswire.com/prnvar/20130715/LA47427LOGO The Tdap vaccination is available every day and no prescription or appointment is necessary. Ralphs pharmacists can vaccinate...

2014-07-01 12:28:59

ROCKVILLE, Md., July 1, 2014 /PRNewswire-USNewswire/ -- Serious adverse events resulting from vaccines routinely used in the United States are rare, according to a report funded by the Agency for Healthcare Research and Quality (AHRQ). The report, highlighted in the July issue of Pediatrics, provides the most comprehensive review to date of published studies on the safety of routine vaccines. "The use of vaccines ranks among the most significant public health achievements," said AHRQ...

2014-05-29 12:28:35

ANNAPOLIS, Md., May 29, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that new analytical data from the Company's SparVax(®) anthrax vaccine program were presented at the 114(th) General Meeting of the American Society for Microbiology (ASM), held recently in Boston, Massachusetts. In a poster presentation entitled "Evidence Correlating Changes in Structure and Biological Activity for a Recombinant Protective Antigen (rPA) Anthrax Vaccine," Dr. Bradford Powell,...

2014-05-21 20:21:45

- Conference call scheduled for Thursday, May 22, 2014 at 8:00 AM EDT - BEIJING, May 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2014. First Quarter 2014 Financial Highlights (period-over-period comparisons to first quarter 2013) -- Quarterly sales increased by 34.8% to $13.5 million from $10.1 million. -- Gross...

2014-05-07 12:26:06

Advisory panel examined vaccine delivery process as a first step toward improvement PHILADELPHIA, May 7, 2014 /PRNewswire/ -- The SHAPE (Storage, Handling, Administration, and Preparation Experts) Vaccine Delivery Working Group announces the publication of a paper discussing issues identified in the vaccine delivery process as a critical first step in continuous process improvement. From Refrigerator to Arm: Identifying Issues in Vaccine Delivery, the first of two papers regarding...

2014-04-28 12:31:40

Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries KING OF PRUSSIA, Pa., April 28, 2014 /PRNewswire/ -- bioCSL, formerly CSL Biotherapies, has announced the donation of more than 700,000 doses of its influenza vaccine to the Partnership for Influenza Vaccine Introduction, an innovative program - spearheaded by the U.S. Centers for Disease Control and Prevention (CDC) and the Task Force for...

2014-04-18 13:37:12

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive option, according to a new study by University of Illinois researchers. “The choice of vaccines to administer can be driven by numerous factors,” says Sheldon H. Jacobson, a co-author of the study and a professor of computer science and of mathematics at the U....

2014-04-01 16:25:27

ANNAPOLIS, Md., April 1, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that data from the Company's SparVax(® )next-generation anthrax vaccine program were recently presented at the 8(th) Annual New Technologies, New Vaccines conference. In a presentation entitled, "Factors that Affect Potency and Stability for a Recombinant Protective Antigen Vaccine," Dr. Bradford Powell, Director, Analytical Sciences at PharmAthene, presented results demonstrating the Company's...

2014-02-26 08:28:23

DORVAL QC, Feb. 26, 2014 /CNW/ - Novartis announced today that Bexsero(®) (Multicomponent Meningococcal B Vaccine [recombinant, adsorbed]) is now available to doctors and pharmacists across Canada. The vaccine is approved for use in individuals from two months through 17 years of age in Canada. Infants, toddlers and adolescents are at the greatest risk of meningococcal serogroup B (MenB) infection.(1) Bexsero(®) is the first broad-coverage vaccine to help protect against MenB...

2014-02-24 08:28:29

- FDA granted special use of Bexsero for nearly 20,000 UCSB students and staff in response to outbreak; the vaccine is licensed in Europe, Australia and Canada CAMBRIDGE, Mass., Feb. 24, 2014 /PRNewswire/ -- Novartis announced today that its meningococcal serogroup B (MenB) vaccine, Bexsero(®) (Meningococcal Group B Vaccine [rDNA, component, adsorbed]), will be used as part of a vaccination program at the University of California Santa Barbara (UCSB) that began today and will end on March 7....


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related